Back
ESC Premium Access

Heart Failure: What are the practical consequences of current and ongoing SGLT2i outcome trials?

Session: Expanding opportunities for SGLT2i in clinical cardiology
Topic: Clinical
Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Organised by PACE-CME, supported with an educational grant provided by Boehringer-Ingelheim/Lilly
Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
100 presentations
4 followers

4 more presentations in this session

Introduction

Speaker: Professor T. Luscher (London, GB)

Access
Slides
Video
Thumbnail

The cardioprotective mechanisms of SGLT2 inhibitors: What do cardiologists need to know?

Speaker: Professor N. Marx (Aachen, DE)

Access
Slides
Video
Thumbnail

Heart & Kidney interactions: What are the challenges for prevention and protection?

Speaker: Professor C. Wanner (Wuerzburg, DE)

Access
Slides
Video
Thumbnail

Panel discussion

Speaker: Professor T. Luscher (London, GB)

Access
Slides
Video
Thumbnail

Access the full session

Expanding opportunities for SGLT2i in clinical cardiology

Speakers: Professor F. Zannad, Professor T. Luscher, Professor N. Marx, Professor C. Wanner, Professor T. Luscher
Access
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb